Nitric oxide-induced cGMP accumulation in the mouse bladder is not related to smooth muscle relaxation

Eur J Pharmacol. 2000 Aug 4;401(2):241-50. doi: 10.1016/s0014-2999(00)00457-x.

Abstract

The functional role of nitric oxide (NO) and the guanylate cyclase/cGMP second messenger system was investigated in the mouse bladder. Electrical field stimulation and the NO-donor 3-morpholino-sydnonimin hydrochloride (SIN-1) did not induce relaxation of the carbachol-precontracted bladder. However, sodium nitroprusside (10(-3) M) was found to enhance the contractile response to electrical field stimulation by 24+/-6% (n=8; P<0.05) without affecting the contractile response to carbachol. The enhancement of bladder contractility evoked by sodium nitroprusside was inhibited by the guanylate cyclase inhibitor 1H-[1,2, 4]oxadiazolo[4,3-a]quinoxalime-1-one (ODQ; 10(-6) M). Incubation of bladder strips with SIN-1 and sodium nitroprusside caused an increase in cGMP accumulation as measured by radioimmunoassay. Immunohistochemical studies showed cGMP-immunoreactivity in nerve fibres and in stromal cells, but not in smooth muscle bundles after exposure to NO-donors. The results show that NO-donors have no inhibitory effect on smooth muscle tone in the mouse bladder, but that NO may have a functional role as an excitatory neuromodulator. The targets of endogenous NO in the bladder may be the demonstrated cGMP-positive structures, i.e., nerves and stromal cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / pharmacology
  • Carbachol / pharmacology
  • Cyclic AMP / metabolism
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / metabolism*
  • Cyclic GMP / pharmacology
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Enzyme Inhibitors / pharmacology
  • Female
  • In Vitro Techniques
  • Mice
  • Mice, Inbred BALB C
  • Molsidomine / analogs & derivatives
  • Molsidomine / pharmacology
  • Muscle Relaxation / drug effects*
  • Muscle, Smooth / drug effects*
  • Muscle, Smooth / physiology
  • Nitric Oxide Donors / pharmacology*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitroarginine / pharmacology
  • Nitroprusside / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Piperazines / pharmacology
  • Piperidines / pharmacology
  • Purines
  • Quinazolines / pharmacology
  • Sildenafil Citrate
  • Sulfones
  • Urethra / drug effects
  • Urethra / metabolism
  • Urethra / physiology
  • Urinary Bladder / drug effects*
  • Urinary Bladder / metabolism
  • Urinary Bladder / physiology

Substances

  • E 4021
  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Piperidines
  • Purines
  • Quinazolines
  • Sulfones
  • Nitroprusside
  • Nitroarginine
  • 8-bromocyclic GMP
  • linsidomine
  • Carbachol
  • Arginine
  • Sildenafil Citrate
  • Molsidomine
  • Cyclic AMP
  • Nitric Oxide Synthase
  • Cyclic GMP